Clinical value of serum long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 in the diagnosis of pulmonary tuberculosis
10.3760/cma.j.issn.1000-6680.2017.11.009
- VernacularTitle:血清长链非编码R N A肺腺癌转移相关转录本1在肺结核中的诊断价值
- Author:
Qing LUO
1
;
Fangyi YAO
;
Yiping PENG
;
Rigu SU
;
Zhen DENG
;
Zikun HUANG
Author Information
1. 330006,南昌大学第一附属医院检验科
- Keywords:
Tuberculosis;
Long non-coding RNA;
MALAT1;
Biomarkers
- From:
Chinese Journal of Infectious Diseases
2017;35(11):684-687
- CountryChina
- Language:Chinese
-
Abstract:
Objective To detect the serum level of long non-coding RNA (lncRNA ) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) in pulmonary tuberculosis (TB) patients ,and to evaluate its diagnostic value .Methods The expression of serum MALAT1 in 56 hospitalized TB patients , 35 latent TB infection (LTBI) individuals and 40 healthy controls were detected by real-time quantitative PCR .Serum levels of MALAT1 before and 3 ,6 months after anti-TB therapy in 16 TB patients were determined .Receiver operating characteristic (ROC) curve analysis was used to evaluate the sensitivity and specificity of serum MALAT 1 .The comparison between two groups was performed by Student t-test , and the comparison among three groups was performed with one-way analysis of variance test .Results Serum level of MALAT1 in TB patients was (2 .10 ± 1 .05) ,which was significantly higher than those in LTBI individuals (1 .16 ± 0 .51) and healthy controls (1 .02 ± 0 .44 ,F= 28 .53 ,P< 0 .01) .The MALAT1 level in TB patients with positive sputum smear was significantly higher than that in patients with negative sputum smear (2 .42 ± 1 .03 vs 1 .43 ± 0 .74 ,t= 2 .66 ,P< 0 .01) .Compared with pre-treatment (2 .28 ± 0 .79) ,the serum MALAT 1 levels decreased significantly in 3 months (1 .35 ± 0 .39) and 6 months (1 .05 ± 0 .30) after anti-TB therapy (t= 4 .33 ,6 .05 ;both P< 0 .01) .The area under the curve (AUC) of serum MALAT1 was 0 .821 , with sensitivity and specificity of 0 .732 and 0 .850 , respectively .Conclusion The expression of MALAT1 is up-regulated in TB patients , and could be used as potential novel biomarkers for the diagnosis of TB .